Woburn, MA · Founded 2018 · Privately Held (backing)
Developer of a data-driven mRNA target identification platform intended to develop RNA-targeting medicines. Rgenta Therapeutics is based in Woburn, MA and was founded in 2018. It was valued at $119 million at its later-stage round in Nov 2022, the last priced event on record. It has raised $98.9 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Nov 2021.
PMV mark · valuation
$119.0M
Oct 2026
Priced at
its later-stage round
Nov 2022
Total raised
$98.9M
Last round
Early Stage VC
Nov 2021
Cap table — not yet on record
Rgenta Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rgenta Therapeutics with a free account
·The complete investor list: 13 names
·Watch Rgenta Therapeutics: the Monday email on marks, rounds and moves
Where does Rgenta Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Rgenta Therapeutics's 2 recorded funding rounds.
